drugset / Trial / NCT01224756

Efficacy of Tinoridine in Treating Pain and Inflammation in Adults

NCT01224756 ↗

Phase 4 Completed 342 enrolled Takeda
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to confirm the efficacy of tinoridine hydrochloride (HCL), three times daily (TID), in the treatment of pain and inflammation in patients with acute tonsillitis and/or acute pharyngitis of nonbacterial origin versus placebo.

Timeline

Start
2010-11
Primary completion
2011-10
Completion
2011-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Tinoridine Small molecule 100 mg Oral

Indications

No indication recorded.